Indeed, there is evidence that markedly elevated circulating pro-inflammatory cytokines such as ET-1, IL-6, vascular cell adhesion molecule-1, and lower levels of cytoprotective factors promote chronic inflammatory responses in the lung and contribute to ACS (51, 52). This evidence concerns the gene IL6 and acute chest syndrome.